https://www.selleckchem.com/products/gne-317.html
When psychosis develops in NMDA receptor (NMDAR) antibody encephalitis, it usually has an acute or subacute onset, and antipsychotic treatment may be ineffective and associated with adverse effects. Serum NMDAR antibodies have been reported in a minority of patients with first-episode psychosis (FEP), but their role in psychosis onset and response to antipsychotic treatment is unclear. Sera from 387 patients with FEP (duration of psychosis 2 years, minimally or never treated with antipsychotics) undergoing initial treatment with ami
Like
Comment
Share
